• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PPAR-γ 药理学(或合成)激动剂和营养激动剂作为 COVID-19 疾病细胞因子风暴调节的候选物。

Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease.

机构信息

Laboratory of Clinical Pathology, Department of Experimental, Diagnostic and Specialty Medicine (DIMES), S. Orsola-Malpighi Hospital, University of Bologna, 40138 Bologna, Italy.

出版信息

Molecules. 2020 Apr 29;25(9):2076. doi: 10.3390/molecules25092076.

DOI:10.3390/molecules25092076
PMID:32365556
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7248959/
Abstract

The cytokine storm is an abnormal production of inflammatory cytokines, due to the over-activation of the innate immune response. This mechanism has been recognized as a critical mediator of influenza-induced lung disease, and it could be pivotal for COVID-19 infections. Thus, an immunomodulatory approach targeting the over-production of cytokines could be proposed for viral aggressive pulmonary disease treatment. In this regard, the peroxisome proliferator-activated receptor (PPAR)-γ, a member of the PPAR transcription factor family, could represent a potential target. Beside the well-known regulatory role on lipid and glucose metabolism, PPAR-γ also represses the inflammatory process. Similarly, the PPAR-γ agonist thiazolidinediones (TZDs), like pioglitazone, are anti-inflammatory drugs with ameliorating effects on severe viral pneumonia. In addition to the pharmacological agonists, also nutritional ligands of PPAR-γ, like curcuma, lemongrass, and pomegranate, possess anti-inflammatory properties through PPAR-γ activation. Here, we review the main synthetic and nutritional PPAR-γ ligands, proposing a dual approach based on the strengthening of the immune system using pharmacological and dietary strategies as an attempt to prevent/treat cytokine storm in the case of coronavirus infection.

摘要

细胞因子风暴是一种炎症细胞因子的异常产生,由于先天免疫反应的过度激活。这一机制已被认为是流感引起的肺部疾病的关键介质,也可能是 COVID-19 感染的关键因素。因此,针对细胞因子过度产生的免疫调节方法可用于治疗病毒性侵袭性肺病。在这方面,过氧化物酶体增殖物激活受体 (PPAR)-γ,PPAR 转录因子家族的一员,可能是一个潜在的靶点。除了对脂质和葡萄糖代谢的众所周知的调节作用外,PPAR-γ 还抑制炎症过程。同样,PPAR-γ 激动剂噻唑烷二酮 (TZDs),如吡格列酮,是具有改善严重病毒性肺炎作用的抗炎药物。除了药理学激动剂外,PPAR-γ 的营养配体,如姜黄、柠檬草和石榴,也通过 PPAR-γ 激活具有抗炎特性。在这里,我们回顾了主要的合成和营养 PPAR-γ 配体,提出了一种基于使用药理学和饮食策略来增强免疫系统的双重方法,试图预防/治疗冠状病毒感染时的细胞因子风暴。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fd/7248959/9aa9a66c208e/molecules-25-02076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fd/7248959/20f5b734d676/molecules-25-02076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fd/7248959/6f6f6c415783/molecules-25-02076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fd/7248959/9aa9a66c208e/molecules-25-02076-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fd/7248959/20f5b734d676/molecules-25-02076-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fd/7248959/6f6f6c415783/molecules-25-02076-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/93fd/7248959/9aa9a66c208e/molecules-25-02076-g003.jpg

相似文献

1
Pharmacological (or Synthetic) and Nutritional Agonists of PPAR-γ as Candidates for Cytokine Storm Modulation in COVID-19 Disease.PPAR-γ 药理学(或合成)激动剂和营养激动剂作为 COVID-19 疾病细胞因子风暴调节的候选物。
Molecules. 2020 Apr 29;25(9):2076. doi: 10.3390/molecules25092076.
2
Differential effects of peroxisome proliferator activated receptor-gamma (PPAR gamma) ligands in proximal tubular cells: thiazolidinediones are partial PPAR gamma agonists.过氧化物酶体增殖物激活受体γ(PPARγ)配体在近端肾小管细胞中的差异效应:噻唑烷二酮类是部分PPARγ激动剂。
Kidney Int. 2004 Jun;65(6):2081-90. doi: 10.1111/j.1523-1755.2004.00624.x.
3
[Progress on role of cytokine storm in exacerbation of coronavirus disease 2019 (COVID-19): Review].[细胞因子风暴在2019冠状病毒病(COVID-19)病情加重中的作用研究进展:综述]
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2020 Oct;36(10):941-947.
4
Protective Effect of Epigallocatechin-3-Gallate (EGCG) in Diseases with Uncontrolled Immune Activation: Could Such a Scenario Be Helpful to Counteract COVID-19?没食子酸表没食子儿茶素(EGCG)在免疫失控性疾病中的保护作用:这种情况是否有助于对抗 COVID-19?
Int J Mol Sci. 2020 Jul 21;21(14):5171. doi: 10.3390/ijms21145171.
5
The Management of Cytokine Storm in COVID-19.新型冠状病毒肺炎细胞因子风暴的管理
Acta Med Indones. 2020 Jul;52(3):306-313.
6
Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis.非诺贝特与吡格列酮:PPAR-α和PPAR-γ激动剂对大鼠佐剂性关节炎抗关节炎效力的比较研究
Biomed Mater Eng. 2014;24(1 Suppl):81-8. doi: 10.3233/BME-140977.
7
Mechanisms of anti-inflammatory and neuroprotective actions of PPAR-gamma agonists.过氧化物酶体增殖物激活受体γ激动剂的抗炎和神经保护作用机制。
Front Biosci. 2008 Jan 1;13:1813-26. doi: 10.2741/2802.
8
Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.过氧化物酶体增殖物激活受体γ配体在缺血再灌注损伤、炎症和休克中的有益作用。
Cardiovasc Res. 2005 Mar 1;65(4):772-81. doi: 10.1016/j.cardiores.2004.12.008.
9
Peroxisome Proliferator-Activated Receptor Gamma (PPAR) Suppresses Inflammation and Bacterial Clearance during Influenza-Bacterial Super-Infection.过氧化物酶体增殖物激活受体 γ(PPARγ)在乙型流感-细菌混合感染期间抑制炎症和细菌清除。
Viruses. 2019 Jun 1;11(6):505. doi: 10.3390/v11060505.
10
Cytokine storm and use of anakinra in a patient with COVID-19.细胞因子风暴及阿那白滞素在一名新冠肺炎患者中的应用
BMJ Case Rep. 2020 Sep 15;13(9):e237525. doi: 10.1136/bcr-2020-237525.

引用本文的文献

1
Aromatic Volatile Compounds of Essential Oils: Distribution, Chemical Perspective, Biological Activity, and Clinical Applications.精油中的芳香挥发性化合物:分布、化学视角、生物活性及临床应用
Food Sci Nutr. 2025 Aug 25;13(9):e70825. doi: 10.1002/fsn3.70825. eCollection 2025 Sep.
2
Selective Activity of Chrysin-6--Fucopyranoside from Toward Peroxisome Proliferator-Activated Receptor Gamma.白杨素-6-O-岩藻糖苷对过氧化物酶体增殖物激活受体γ的选择性活性
Molecules. 2025 Apr 5;30(7):1626. doi: 10.3390/molecules30071626.
3
Medicinal Perspective of 2,4-Thiazolidinediones Derivatives: An Insight into Recent Advancements.

本文引用的文献

1
Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods.通过计算方法分析严重急性呼吸综合征冠状病毒2(SARS-CoV-2)的治疗靶点并发现潜在药物
Acta Pharm Sin B. 2020 May;10(5):766-788. doi: 10.1016/j.apsb.2020.02.008. Epub 2020 Feb 27.
2
Different Drugs Effect on Mesenchymal Stem Cells Isolated From Abdominal Aortic Aneurysm.不同药物对从腹主动脉瘤中分离出的间充质干细胞的影响。
Ann Vasc Surg. 2020 Aug;67:490-496. doi: 10.1016/j.avsg.2020.03.001. Epub 2020 Mar 12.
3
Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
2,4-噻唑烷二酮衍生物的药用视角:近期进展洞察
ChemistryOpen. 2024 Nov;13(11):e202400147. doi: 10.1002/open.202400147. Epub 2024 Sep 9.
4
Role of Curcuma longae Rhizoma in medical applications: research challenges and opportunities.姜黄在医学应用中的作用:研究挑战与机遇。
Front Pharmacol. 2024 Aug 6;15:1430284. doi: 10.3389/fphar.2024.1430284. eCollection 2024.
5
The Effect of Antihyperglycemic Medications on COVID-19: A Meta-analysis and Systematic Review from Observational Studies.抗高血糖药物对 COVID-19 的影响:来自观察性研究的荟萃分析和系统评价。
Ther Innov Regul Sci. 2024 Jul;58(4):773-787. doi: 10.1007/s43441-024-00633-6. Epub 2024 Apr 29.
6
Identification of shared pathogenetic mechanisms between COVID-19 and IC through bioinformatics and system biology.通过生物信息学和系统生物学鉴定 COVID-19 和 IC 之间的共同发病机制。
Sci Rep. 2024 Jan 24;14(1):2114. doi: 10.1038/s41598-024-52625-z.
7
Inhibition of miR-96-5p alleviates intervertebral disc degeneration by regulating the peroxisome proliferator-activated receptor γ/nuclear factor-kappaB pathway.抑制 miR-96-5p 通过调节过氧化物酶体增殖物激活受体 γ/核因子-κB 通路缓解椎间盘退变。
J Orthop Surg Res. 2023 Dec 1;18(1):916. doi: 10.1186/s13018-023-04412-1.
8
A glimpse of the connection between PPARγ and macrophage.PPARγ与巨噬细胞之间联系的一瞥。
Front Pharmacol. 2023 Aug 28;14:1254317. doi: 10.3389/fphar.2023.1254317. eCollection 2023.
9
Pharmacological properties and underlying mechanisms of aurantio‑obtusin (Review).橙皮素的药理特性及潜在机制(综述)
Exp Ther Med. 2023 Jun 26;26(2):380. doi: 10.3892/etm.2023.12079. eCollection 2023 Aug.
10
PI3K/Akt/Nrf2 mediated cellular signaling and virus-host interactions: latest updates on the potential therapeutic management of SARS-CoV-2 infection.PI3K/Akt/Nrf2介导的细胞信号传导与病毒-宿主相互作用:SARS-CoV-2感染潜在治疗管理的最新进展
Front Mol Biosci. 2023 Jun 1;10:1158133. doi: 10.3389/fmolb.2023.1158133. eCollection 2023.
新型冠状病毒肺炎(COVID-19)具有独特的流行病学和临床特征,提示应采取特殊的控制措施。
J Med Virol. 2020 Jun;92(6):568-576. doi: 10.1002/jmv.25748. Epub 2020 Mar 29.
4
[Advances in the research of mechanism and related immunotherapy on the cytokine storm induced by coronavirus disease 2019].[新型冠状病毒肺炎细胞因子风暴的机制及相关免疫治疗研究进展]
Zhonghua Shao Shang Za Zhi. 2020 Jun 20;36(6):471-475. doi: 10.3760/cma.j.cn501120-20200224-00088.
5
Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer.两例肺癌患者 2019 年新型冠状病毒(COVID-19)肺炎早期阶段的肺部病理学表现。
J Thorac Oncol. 2020 May;15(5):700-704. doi: 10.1016/j.jtho.2020.02.010. Epub 2020 Feb 28.
6
Exploration and Development of PPAR Modulators in Health and Disease: An Update of Clinical Evidence.PPAR 调节剂在健康与疾病中的探索与开发:临床证据的更新。
Int J Mol Sci. 2019 Oct 11;20(20):5055. doi: 10.3390/ijms20205055.
7
PubChem 2019 update: improved access to chemical data.PubChem 2019 年更新:改善化学数据获取。
Nucleic Acids Res. 2019 Jan 8;47(D1):D1102-D1109. doi: 10.1093/nar/gky1033.
8
Peroxisome proliferator-activated receptor γ (PPARγ) induces the gene expression of integrin αβ to promote macrophage M2 polarization.过氧化物酶体增殖物激活受体 γ(PPARγ)诱导整合素 αβ 的基因表达,促进巨噬细胞 M2 极化。
J Biol Chem. 2018 Oct 26;293(43):16572-16582. doi: 10.1074/jbc.RA118.003161. Epub 2018 Sep 4.
9
Cytokine release syndrome.细胞因子释放综合征。
J Immunother Cancer. 2018 Jun 15;6(1):56. doi: 10.1186/s40425-018-0343-9.
10
The crosstalk between vascular MSCs and inflammatory mediators determines the pro-calcific remodelling of human atherosclerotic aneurysm.血管间充质干细胞与炎症介质之间的相互作用决定了人类动脉粥样硬化性动脉瘤的促钙化重塑。
Stem Cell Res Ther. 2017 Apr 26;8(1):99. doi: 10.1186/s13287-017-0554-x.